Back to search

Article

Development of the first low nanomolar Liver Receptor Homolog-1 agonist through structure-guided design

2019-05-17

Abstract excerpt

<h4>ABSTRACT</h4> As a key regulator of metabolism and inflammation, the orphan nuclear hormone receptor, Liver Receptor Homolog-1 (LRH-1), has potential as a therapeutic target for diabetes, nonalcoholic fatty liver disease, and inflammatory bowel diseases. Discovery of LRH-1 modulators has been difficult, in part due to the tendency for synthetic compounds to bind unpredictably within the lipophilic binding poc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5742c10-2f46-5e8c-a124-b8179ec8614d
DOI
10.1101/639732
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of the first low nanomolar Liver Receptor Homolog-1 agonist through structure-guided designDOI 10.1101/639732
Select a neighboring publication to make it the new centre.